EVALUATION STUDIES, FDA PHASE 1
\ɪvˌaljuːˈe͡ɪʃən stˈʌdɪz], \ɪvˌaljuːˈeɪʃən stˈʌdɪz], \ɪ_v_ˌa_l_j_uː_ˈeɪ_ʃ_ə_n s_t_ˈʌ_d_ɪ_z]\
Sort: Oldest first
-
Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.
By DataStellar Co., Ltd
Nearby Words
- evaluation studies
- evaluation studies (pub type)
- evaluation studies [pt]
- evaluation studies [publication type]
- evaluation studies, drug, preclinical
- Evaluation Studies, FDA Phase 1
- evaluation studies, fda phase 2
- evaluation studies, fda phase 3
- evaluation studies, fda phase 4
- evaluation studies, fda phase i
- evaluation studies, fda phase ii